Trials / Completed
CompletedNCT01694966
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,249 (actual)
- Sponsor
- Cosmo Technologies Ltd · Industry
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of the histologically proven adenoma and carcinoma detection rate in patients undergoing a full colonoscopy with and without mucosal contrast enhancement, obtained with 200 mg of Methylene Blue MMX® tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylene Blue MMX® | |
| DRUG | Placebo | Sugar pill manufactured to mimic Methylene Blue MMX® tablet. |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2012-09-27
- Last updated
- 2017-11-06
- Results posted
- 2017-11-06
Locations
19 sites across 8 countries: United States, Belgium, Canada, Germany, Italy, Lithuania, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT01694966. Inclusion in this directory is not an endorsement.